Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis

Cutis

Volumn 81, Issue 5, 2008, Pages 435-441

  Conde, Jennifer F ^a   Kaur, Mandeep ^a   Fleischer Jr , Alan B ^a   Tusa, Mark G ^a   Camacho, Fabian ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOCORTOLONE PIVALATE; DRUG DERIVATIVE; FLUOCORTOLONE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CAREGIVER; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG MONITORING; DRUG SELF ADMINISTRATION; ELECTRONICS; HOSPITALIZATION; HUMAN; INSTRUMENTATION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; PATHOLOGY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SKIN; STATISTICS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; CAREGIVERS; CHILD; DERMATITIS, ATOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; ELECTRONICS, MEDICAL; FLUOCORTOLONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PATIENT COMPLIANCE; SELF ADMINISTRATION; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME;

EID: 44649165745     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Laughter D, Istvan JA, Tofte SJ, et al. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000;43:649-655.
2. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103:125-138.
3. Odom RB, James WD, Berger TG. Atopic dermatitis. In: Odom RB, James WD, Berger TG, eds. Andrews' Diseases of the Skin: Clinical Dermatology. 10th ed. Philadelphia, PA: WB Saunders; 2005:69-77.
4. Schafer T, Ring J. Epidemiology of allergic diseases. Allergy. 1997;52:14-22.
5. Schultz LF. Atopic dermatitis: an increasing problem. Pediatr Allergy Immunol. 1996;7:51-53.
6. Leung DY, Tharp M, Boguniewicz M. Atopic dermatitis. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 2005:1464-1480.
7. Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement, implications for dermatology. Am J Clin Dermatol. 2001;2:7-12.
8. Murphy J, Coster G. Issues in patient compliance. Drugs. 1997;54:797-800.
9. Eisen SA, Woodward RS, Miller D, et al. The effect of medication compliance on the control of hypertension. J Gen Intern Med. 1987;2:298-305.
10. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
11. Urquhart J. Role of patient compliance in clinical pharmacokinetics: a review of recent research. Clin Pharmacokinet. 1994;27:202-215.
12. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Int Med. 1990;150:1509-1510.
13. Urquhart J. The electronic medication event monitor lessons for pharmacotherapy. Clin Pharmacokinet. 1997;32:345-356.
14. Balkrishnan R, Carroll CL, Camacho FT, et al. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol. 2003;49:651-654.
15. Turner BJ, Hecht FM. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med. 2001;134:1004-1006.
16. Urquhart J. Pharmionics: research on what patients do with prescription drugs. Pharmacoepidemiol Drug Saf. 2004;13:587-590.
17. Urquhart J. The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol. 2002;54:212-220.
18. Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56:211-216.